Abstract
Research Overview
Difficulty to Quantify Exact Benefits Cheminformatics Brings to Drug Discovery Reducing the Marketability
Though cheminformatics tools have been around for a long time, they clearly
quantify the productivity increments they bring around in the R&D process.
With many pharmaceutical companies tightening their budget for informatics
tools, there is a shift in the purchase decisions towards ROI calculations
rather than the price. It makes it easier for the decision makers in the
pharmaceutical companies to approve purchases of well validated tools, which
have a clear business case of good ROI.
Need for Data Integration and Knowledge Management Driving the Demand for the Informatics Tools
The globalisation of research efforts resulted in vast pools of scientific
resources spread across the globe for the pharmaceutical needs. There is an
increasing need for them to streamline the research efforts and effectively
utilise the information which is being created. Informatics tools such as
cheminformatics are playing a greater role to bring around integration and
knowledge management.
Developments in Computing Hardware Boosting the Uptake of More Complex Chemical Analytical and Modelling Tools
Computer hardware industry is witnessing a quantum jump in the capabilities of
computing power of the systems being sold. The systems are not only becoming
more powerful, but also cheaper bringing them within the reach of a vast
majority of scientists. With this new computing power, scientists are now able
to perform complex modeling and simulation exercises such as in-silico design
of drugs, virtual screening and docking experiments at speed which were never
witnessed before. High performance computing infrastructure in the
pharmaceutical companies is bringing around an increased uptake and
development of newer and sophisticated tools to effectively utilise this jump
in the computing power to solve the drug development challenges.
| 
View Cart
